David H. Wang, Chief Executive Officer, President, and Director of ACM Research, Inc. (NASDAQ:ACMR), filed a Form 4 on November 19, 2026, disclosing the exercise of stock options and sale of Class A Common Stock on November 17 and 18, 2026.
Key Highlights
- Option exercises: Wang exercised two stock options, each for 65,000 shares of Class A Common Stock at an exercise price of $1 per share, one on November 17 and one on November 18, 2026.
- Shares sold: A total of 129,000 shares were sold across both days at weighted average prices ranging from approximately $42.71 to $45.02 per share.
- Remaining direct holdings: Following all reported transactions, Wang directly held 802,708 shares of Class A Common Stock.
- Rule 10b5-1 plan: All sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Wang on June 5, 2026, according to the filing.
- Indirect holdings: The filing also reports 100,002 shares held by Wang's wife Jing Chen, 180,000 shares held by the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children, and 620,001 shares held by the Wang-Chen Family Living Trust.
- Remaining options: Following both exercises, Wang held 0 stock options directly, with the options having an expiration date of December 27, 2026.
Wang Exercises Options and Sells ACM Research Shares Under 10b5-1 Plan
According to the Form 4 filed with the SEC on November 19, 2026, David H. Wang, who serves as Chief Executive Officer, President, and Director of ACM Research, Inc., reported two separate option exercise and stock sale transactions on consecutive trading days. On November 17, 2026, Wang exercised a stock option for 65,000 shares at $1 per share (transaction code M) and subsequently sold a total of 64,000 shares in four separate sale transactions. The weighted average sale prices for those transactions were $42.71, $43.32, $44.43, and $45.02 per share, with actual individual transaction prices ranging across multiple sub-ranges within those levels.
On November 18, 2026, Wang again exercised a stock option for 65,000 shares at $1 per share and sold a combined 65,000 shares in two transactions at weighted average prices of $43.28 and $44.12 per share. The filing notes that shares on November 18 were sold at prices ranging from $42.81 to $44.67, inclusive. The filing states that all sales were made under a Rule 10b5-1 trading plan that Wang adopted on June 5, 2026, and that both exercised options were "fully vested and exercisable" at the time of the transactions.
After all reported activity, Wang's direct beneficial ownership stood at 802,708 shares of Class A Common Stock. In addition to direct holdings, the filing discloses indirect ownership of 100,002 shares held by his wife Jing Chen, 180,000 shares held by the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children, and 620,001 shares held by the Wang-Chen Family Living Trust. The filing was signed by Mark McKechnie as Attorney-in-Fact for David H. Wang on November 19, 2026.
What Was Disclosed
ACM Research CEO David H. Wang disclosed the exercise of two stock options totaling 130,000 shares and the sale of 129,000 shares of Class A Common Stock on November 17 and 18, 2026, under a pre-established Rule 10b5-1 trading plan, leaving him with 802,708 directly held shares.



Please wait processing your request...